BodyGuard Life Science -Website Under Maintenance!, page-112

Agree on this. If you clearly can't forecast reasonably accurately it is not in your interest to do so. Another company I am invested in AJX, went from virtually zero revenues to $14mill in one year, yet they forecast $24mill and have subsequently been punished.

It is extremely difficult for any fledgling company beginning its first revenue stream to accurately gauge revenues. There are so many variables that can significantly alter the forecasts. Forecasting only once repetitive and sustainable revenue flows are evident is the sensible thing to do.